<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900613-0036</DOCNO><DOCID>900613-0036.</DOCID><HL>   Professor Named to Probe   Case of Revco Drug's LBO</HL><DATE>06/13/90</DATE><SO>WALL STREET JOURNAL (J), PAGE A2</SO><CO>   RDS</CO><IN>BANKRUPTCIES (BCY)DRUG-BASED RETAILERS AND WHOLESALERS, PHARMACIES (RTD)</IN><LP>   NEW YORK -- U.S. Bankruptcy Court Judge Harold F. Whiteapproved the appointment of Barry L. Zaretsky, a Brooklyn LawSchool professor and counsel to the international law firm ofKelley Drye andamp; Warren, as examiner in the Revco Drugstoresbankruptcy case, according to the law firm.   Appointment of an examiner in the case was requested byU.S. Trustee Conrad J. Morgenstern.</LP><TEXT>   The law firm said that Prof. Zaretsky, with Kelley Drye ashis counsel, will investigate the failed $1.25 billionmanagement-led leveraged buy-out of the 2,000-drugstorechain. It was the first major junk-bond-financed LBO to enterChapter 11 of the Bankruptcy Code under which a company isgiven protection from creditors while it tries to work out aplan for paying its debts.   Prof. Zaretsky will seek to determine whether the RevcoLBO involved fraud and is to submit a preliminary report July16.   The law firm said that if Prof. Zaretsky's investigationfinds that the LBO was fraudulent and if the courtsultimately uphold such findings, it would further jeopardizejunk-bond-financed LBOs as a method of corporate acquisition.The law firm added that if fraud is found in the Revco case,it could retroactively call into question billions of dollarsof LBO debt outstanding.</TEXT></DOC>